type="main" <title type="main">ABSTRACT</title> <p>Governments often subsidize poorer groups in society to ensure their access to new drugs. We analyse the optimal income-based price subsidies in a strategic environment. We show that universal access is less likely to arise when price arbitrage prevents international price...</p>